Rxi Pharmaceuticals Corp (NASDAQ:RXII)

2.76
Delayed Data
As of Apr 19
 +0.025 / +0.92%
Today’s Change
2.51
Today|||52-Week Range
7.70
-50.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash8.5M5.2M13.0M3.6M
 
 
 
 
 
Short Term Investment Cash-2.9M-3.4M7.8M-9.3M
 
 
 
 
 
Cash & Short Term Investments8.5M10.7M13.0M3.6M
 
 
 
 
 
 
ReceivablesReceivables--0.000.000.00--
 
InventoriesInventories--0.000.000.00--
 
Current AssetsPrepaid Expenses--311.0K150.0K--
 
 
 
Other Current Assets442.0K0.000.00201.0K
 
 
 
Current Assets9.0M11.0M13.1M3.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross885.0K941.0K945.0K1.1M
 
 
 
 
 
Depreciation-702.0K-778.0K-831.0K-900.0K
 
 
 
 
 
Other Assets18.0K18.0K22.5K18.0K
 
 
 
 
 
Total Assets9.2M11.2M13.4M4.1M
 
 
 
 
 
 
LiabilitiesAccounts Payable285.0K1.2M917.0K511.0K
 
 
 
 
 
Accrued Expenses469.0K1.1M880.0K1.0M
 
 
 
 
 
Other Current Liabilities521.0K1.1M880.0K1.0M
 
 
 
 
 
Other Liabilities1.3M2.3M2.5M2.3M
 
 
 
 
 
 
Total LiabilitiesTotal Liabilities1.3M2.3M2.5M2.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock6.7M0.003.5M0.00
 
 
 
Common Equity1.2M8.9M7.3M1.8M
 
 
 
 
 
Total Shareholder Equity7.9M8.9M10.9M1.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding219.8K653.5K1.3M2.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.